1492 Capital Management’s Biofrontera AG American Depositary Shares BFRA Stock Holding History

1492 Capital Management’s Portfolio BFRA Stock Details BFRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-12,607	Closed	-$69K	–	125
2021 Q3	$69K	Buy	12,607 +107	+0.9%	+$631	0.03%	108
2021 Q2	$80K	Hold	12,500	–	–	0.04%	110
2021 Q1	$67K	Buy	+12,500	New	+$88.8K	0.04%	99

Other funds holding BFRA

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

1492 Capital Management's BFRA Position: Q4 2021 in Review

1492 Capital Management sold out of Biofrontera AG American Depositary Shares (BFRA) in Q4 2021, closing a stake of 12,607 shares — an estimated $69K sold.

1492 Capital Management first reported a position in BFRA in Q1 2021 and held it in 3 quarters. The position peaked at $80K in Q2 2021. 3 funds tracked by Wall St. Rank hold BFRA as of Q4 2021.

1492 Capital Management reported no remaining Biofrontera AG American Depositary Shares position as of Q4 2021 after selling out during the quarter.
1492 Capital Management sold 12,607 Biofrontera AG American Depositary Shares shares in Q4 2021, an estimated $69K.
1492 Capital Management first reported a position in Biofrontera AG American Depositary Shares in Q1 2021 and held it in 3 quarters.
1492 Capital Management's Biofrontera AG American Depositary Shares position peaked at $80K in Q2 2021.
3 funds tracked by Wall St. Rank held Biofrontera AG American Depositary Shares as of Q4 2021.

Based on 1492 Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.